613 related articles for article (PubMed ID: 34643675)
21. Both endothelial mineralocorticoid receptor expression and hyperleptinemia are required for clinical characteristics of placental ischemia in mice.
Moronge D; Ayulo V; Elgazzaz M; Mellott E; Ogbi S; Faulkner JL
Am J Physiol Heart Circ Physiol; 2024 Jul; 327(1):H118-H130. PubMed ID: 38758130
[TBL] [Abstract][Full Text] [Related]
22. Myeloperoxidase in the plasma and placenta of normal pregnant women and women with pregnancies complicated by preeclampsia and intrauterine growth restriction.
Hung TH; Chen SF; Lo LM; Li MJ; Yeh YL; Hsieh TT
Placenta; 2012 Apr; 33(4):294-303. PubMed ID: 22264587
[TBL] [Abstract][Full Text] [Related]
23. Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta.
Huebner H; Hartner A; Rascher W; Strick RR; Kehl S; Heindl F; Wachter DL; Beckmann Md MW; Fahlbusch FB; Ruebner M
Reprod Sci; 2018 Sep; 25(9):1357-1370. PubMed ID: 29246089
[TBL] [Abstract][Full Text] [Related]
24. The role of epigenetic changes in preeclampsia.
Kamrani A; Alipourfard I; Ahmadi-Khiavi H; Yousefi M; Rostamzadeh D; Izadi M; Ahmadi M
Biofactors; 2019 Sep; 45(5):712-724. PubMed ID: 31343798
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation loci in placenta associated with birthweight and expression of genes relevant for early development and adult diseases.
Tekola-Ayele F; Zeng X; Ouidir M; Workalemahu T; Zhang C; Delahaye F; Wapner R
Clin Epigenetics; 2020 Jun; 12(1):78. PubMed ID: 32493484
[TBL] [Abstract][Full Text] [Related]
26. Placental ABCA1 and ABCG1 expression in gestational disease: Pre-eclampsia affects ABCA1 levels in syncytiotrophoblasts.
Baumann M; Körner M; Huang X; Wenger F; Surbek D; Albrecht C
Placenta; 2013 Nov; 34(11):1079-86. PubMed ID: 23880356
[TBL] [Abstract][Full Text] [Related]
27. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
[TBL] [Abstract][Full Text] [Related]
28. No evidence of the unfolded protein response in the placenta of two rodent models of preeclampsia and intrauterine growth restriction.
Denkl B; Cordasic N; Huebner H; Menendez-Castro C; Schmidt M; Mocker A; Woelfle J; Hartner A; Fahlbusch FB
Biol Reprod; 2021 Aug; 105(2):449-463. PubMed ID: 33955453
[TBL] [Abstract][Full Text] [Related]
29. Prenatal Growth Patterns and Birthweight Are Associated With Differential DNA Methylation and Gene Expression of Cardiometabolic Risk Genes in Human Placentas: A Discovery-Based Approach.
Chen PY; Chu A; Liao WW; Rubbi L; Janzen C; Hsu FM; Thamotharan S; Ganguly A; Lam L; Montoya D; Pellegrini M; Devaskar SU
Reprod Sci; 2018 Apr; 25(4):523-539. PubMed ID: 28693373
[TBL] [Abstract][Full Text] [Related]
30. Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction.
Pecks U; Rath W; Caspers R; Sosnowsky K; Ziems B; Thiesen HJ; Maass N; Huppertz B
Placenta; 2013 Dec; 34(12):1142-9. PubMed ID: 24404588
[TBL] [Abstract][Full Text] [Related]
31. Pre-eclampsia onset and SPARC: A possible involvement in placenta development.
Tossetta G; Fantone S; Giannubilo SR; Marinelli Busilacchi E; Ciavattini A; Castellucci M; Di Simone N; Mattioli-Belmonte M; Marzioni D
J Cell Physiol; 2019 May; 234(5):6091-6098. PubMed ID: 30426491
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs in Uteroplacental Vascular Dysfunction.
Hu XQ; Zhang L
Cells; 2019 Oct; 8(11):. PubMed ID: 31671866
[TBL] [Abstract][Full Text] [Related]
33. Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or intrauterine growth retardation.
Faxén M; Nasiell J; Blanck A; Nisell H; Lunell NO
Am J Perinatol; 1998 Jan; 15(1):9-13. PubMed ID: 9475680
[TBL] [Abstract][Full Text] [Related]
34. Regulatory effect of miR-195 in the placental dysfunction of preeclampsia.
Gunel T; Kamali N; Hosseini MK; Gumusoglu E; Benian A; Aydinli K
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):901-908. PubMed ID: 30078346
[No Abstract] [Full Text] [Related]
35. Identification of miR-210-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction, and its potential role in the pregnancy complications.
Awamleh Z; Han VKM
Pregnancy Hypertens; 2020 Jan; 19():159-168. PubMed ID: 32014817
[TBL] [Abstract][Full Text] [Related]
36. Disruption of maternal vascular remodeling by a fetal endoretrovirus-derived gene in preeclampsia.
Gong X; He W; Jin W; Ma H; Wang G; Li J; Xiao Y; Zhao Y; Chen Q; Guo H; Yang J; Qi Y; Dong W; Fu M; Li X; Liu J; Liu X; Yin A; Zhang Y; Wei Y
Genome Biol; 2024 May; 25(1):117. PubMed ID: 38715110
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of mTOR related molecules in the placenta from gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR) and preeclampsia patients.
Tsai K; Tullis B; Jensen T; Graff T; Reynolds P; Arroyo J
Reprod Biol; 2021 Jun; 21(2):100503. PubMed ID: 33826986
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of STAT5A and its role as fetal DNA epigenetic marker during placental development and dysfunction.
Rahat B; Thakur S; Bagga R; Kaur J
Placenta; 2016 Aug; 44():46-53. PubMed ID: 27452437
[TBL] [Abstract][Full Text] [Related]
39. Genome-wide placental DNA methylation analysis of severely growth-discordant monochorionic twins reveals novel epigenetic targets for intrauterine growth restriction.
Roifman M; Choufani S; Turinsky AL; Drewlo S; Keating S; Brudno M; Kingdom J; Weksberg R
Clin Epigenetics; 2016; 8():70. PubMed ID: 27330572
[TBL] [Abstract][Full Text] [Related]
40. A mechanism for the effect of endocrine disrupting chemicals on placentation.
Yang C; Song G; Lim W
Chemosphere; 2019 Sep; 231():326-336. PubMed ID: 31132539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
